Schizophrenia Clinical Trial
— GEBRCTOfficial title:
Meaningful Change With the Method Guided Self-Determination - a Randomised Controlled Study for Patients Diagnosed With Schizophrenia.
Background:
Rehospitalisation and discontinued treatment are common among patients with schizophrenia
and is often associated with lack of insight into the illness. Improving patients' insight
has been attempted through psychoeducation and standard treatment but without any
considerable change. A newly developed method, Guided Self-Determination (GSD), originally
developed and proved effective in difficult diabetes care has been adjusted to patients with
schizophrenia. A qualitative evaluation of GSD has shown a positive influence on patients'
insight into the illness.
Aim and hypotheses: The aim of the study is to evaluate the effects of the method GSD in the
care of patients with schizophrenia compared to treatment as usual. The following hypotheses
will be tested:
The method GSD will improve: Cognitive and clinical insight in patients, various domains of
recovery, patients' self-esteem, psychopathology and social functioning.
Material and method:
The study design is a randomised controlled trial. The participants are diagnosed with
schizophrenia and schizoaffective disorder, receiving treatment in 3 Assertive Outreach
Teams and 3 Psychosis Teams in Region North. Participants complete four self-rating
questionnaires, a demographic data sheet, an interview concerning psychopathology and an
assessment of social functioning at baseline, and after 3, 6, and 12 month. All assessments
will be conducted by the investigator, except for the assessment of social functioning, that
will be measures by community nurses. Intervention with the method GSD will also be
conducted by the community nurses but under supervision from the investigator. Fifty
patients are randomly assigned to immediate receipt of individual training with the method
GSD (intervention group) and 50 to a 12-month waiting list for individual training with the
method GSD (control group).
Perspectives:
In mental health nursing practice in Denmark there is no tradition for empirical research as
the basis of psychiatric nursing - unverified theories or general empirical consensus of
good clinical practice are often the foundation of psychiatric nursing. If the method GSD
proves effective in the care of patients with schizophrenia, this study contributes to an
evidence based nursing intervention, which is ready for further research on implementation
in mental health nursing practice.
| Status | Completed |
| Enrollment | 101 |
| Est. completion date | July 2012 |
| Est. primary completion date | July 2012 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 70 Years |
| Eligibility |
Inclusion Criteria: - Patient's hospital record meeting the criteria for schizophrenia according to ICD-10 F.20.0-9 or schizoaffective disorder according to ICD-10 F.25.0-9 - Age 18 - 70 years at the time of inclusion - Ability to understand, speak and write Danish - assessed by the community nurse - Informed written consent - receiving treatment in an assertive outreach team or psychosis team in region north in Denmark Exclusion Criteria: - Previous participation with the method GSD - Patients who are mentally handicapped or diagnosed with any kind of dementia or an organic brain disease according to their hospital record - In need of an interpreter to understand, speak and write Danish - Withdrawal of informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| Denmark | Psychiatry in Region North Jutland | Aalborg | North Jutland |
| Lead Sponsor | Collaborator |
|---|---|
| University of Aarhus | Aalborg Psychiatric Hospital |
Denmark,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | changes in cognitive insight over time | Cognitive insight is measured by the selvrating questionnaire Beck Cognitive Insight Scale (BCIS). | baseline, 3,6 and 12 month | No |
| Secondary | Changes in Clinical insight over time | Clinical insight is measured by the self-rating questionnaire "Birchwood Insight Scale" | baseline, 3,6,12 month | No |
| Secondary | changes in various domains of recovery over time | recovery is measured by the self-rating questionnaire "Recovery Assessment Scale" | baseline, 3,6,12 month | No |
| Secondary | changes in self-esteem over time | self-esteem is measured by the self-rating questionnaire "Rosenberg self-esteem scale" | baseline, 3,6,12 month | No |
| Secondary | changes in psychopathology over time | Psychopathology is measured by the PANSS - "Positive and Negative Symptom Scale" | baseline, 3,6,12 month | No |
| Secondary | changes of social function over time | Social function is measured by GAF - "Global Assessment Scale" | baseline, 3,6,12 month | No |
| Secondary | Therapeutic relationship | Therapeutic relationship is measured by STAR - "Scale to assess Therapeutic Relationship in Community Mental Health Care" patient version | 12 month | No |
| Secondary | Therapeutic relationship | Therapeutic relationship is measured by HAS - "Helping Alliance Scale" | 12 month | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
| Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
| Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
| Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
| Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
| Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
| Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
| Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
| Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
| Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
| Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
| Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
| Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
| Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
| Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
| Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
| Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
| Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
| Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |